Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)

NARecruitingINTERVENTIONAL
Enrollment

274

Participants

Timeline

Start Date

August 17, 2021

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2027

Conditions
Pancreatic CancerLung Cancer, Nonsmall Cell
Interventions
OTHER

Supportive application with integrated weekly PRO

Patients will fill in a web-based application PRO-CTCAE with integrated preparation questionnaire every week. If their weekly reported symptoms exceed a predefined threshold of severity, this results in a notification on the staff application interface and a nurse will contact a patient for verification of symptoms. Nurse will review patient recent treatment and PRO reports and advise patient according to the local practice for symptom management and reinforce reporting. Nurse will consult with or refers to (if possible) treating physician if patient will require medical intervention and/or physician assistance.

Trial Locations (1)

2730

RECRUITING

Herlev & Gentofte University Hospital, Denmark, Herlev

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Inna Chen, MD

OTHER